Edwards Lifesciences Corp

SCHRODER INVESTMENT MANAGEMENT GROUP EW

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/14/2024

Shares

649,980

Value ($000)

62,112

Weight

0.1%

2013 Q4 - 2024 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/14/2024	62,112	0.1%	649,980	3/31/2024
2022 Q4	2/10/2023	38,791	0.1%	519,916	12/31/2022
2022 Q3	11/14/2022	65,446	0.1%	792,050	9/30/2022
2022 Q2	8/11/2022	260,731	0.4%	2,741,947	6/30/2022
2022 Q1	5/16/2022	338,422	0.4%	2,890,266	3/31/2022
2021 Q4	2/14/2022	373,735	0.5%	2,884,873	12/31/2021
2021 Q3	11/12/2021	255,290	0.4%	2,255,005	9/30/2021
2021 Q2	8/13/2021	238,356	0.3%	2,301,404	6/30/2021
2021 Q1	5/28/2021	165,971	0.2%	1,984,351	3/31/2021
2020 Q4	2/16/2021	204,895	0.3%	2,245,917	12/31/2020
2020 Q3	11/13/2020	193,009	0.3%	2,449,033	9/30/2020
2020 Q2	8/13/2020	69,460	0.1%	1,005,057	6/30/2020
2020 Q1	5/15/2020	24,402	0.1%	124,869	3/31/2020
2019 Q4	2/11/2020	34,437	0.1%	147,615	12/31/2019
2014 Q1	5/15/2014	771	0.0%	10,400	3/31/2014
2013 Q4	2/14/2014	6,037	0.0%	91,800	12/31/2013